Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for prevention of vancomycin + piperacillin-tazobactam nephrotoxicity
IRCT20100228003449N26Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of magnesium sulfate in acute kidney failure (AKF) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of acute kidney injury. Started Sep 2019; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20100228003449N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100228003449N26.